<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202014000100019</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Rehabilitación cardíaca después de un síndrome coronario agudo]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Burdiat]]></surname>
<given-names><![CDATA[Gerard]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Asociación Española Servicio de Cardiología ]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2014</year>
</pub-date>
<volume>29</volume>
<numero>1</numero>
<fpage>153</fpage>
<lpage>163</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202014000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202014000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202014000100019&amp;lng=en&amp;nrm=iso"></self-uri><kwd-group>
<kwd lng="es"><![CDATA[SINDROME CORONARIO AGUDO]]></kwd>
<kwd lng="es"><![CDATA[REHABILITACIÓN]]></kwd>
<kwd lng="en"><![CDATA[ACUTE CORONARY SYNDROME]]></kwd>
<kwd lng="en"><![CDATA[REHABILITATION]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[       <basefont size="3"> <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"><b>Art&iacute;culo de revisi&oacute;n&nbsp;</b></font></p>          <p align="left"><b><font face="Verdana" size="4"> Rehabilitaci&oacute;n card&iacute;aca despu&eacute;s      de un s&iacute;ndrome coronario agudo&nbsp; </font></b></p>          <p align="left"><font face="Verdana" size="2"> Dr. Gerard Burdiat</font><sup><font face="Verdana" size="2"><a name="-a"></a></font><font color="#d62437" face="Verdana" size="2"><a href="#a">1</a></font><font face="Verdana" size="2">&nbsp;</font></sup><font face="Verdana" size="2"> </font><font face="Verdana"><font size="2">    <br>      </font>      <basefont size="3"> </font> </p>          <p align="left"><font face="Verdana" size="2"><a name="a"></a> </font> <font color="#1f1a17" face="Verdana" size="2"> <a href="#-a">1</a></font><font face="Verdana" size="2">. Cardi&oacute;logo. Servicio de Cardiolog&iacute;a. Asociaci&oacute;n Espa&ntilde;ola. Montevideo,   Uruguay.     <br>        Correo electr&oacute;nico: </font> <font color="#1f1a17" face="Verdana" size="2"> <a href="mailto:gburdiat@mednet.org.uy">gburdiat@mednet.org.uy</a></font><font face="Verdana" size="2">&nbsp;</font></p> <font face="Verdana" size="2"><b>Palabras clave:</b>    <br>       &nbsp;&nbsp;&nbsp;&nbsp;SINDROME CORONARIO AGUDO    <br> &nbsp; &nbsp; REHABILITACI&Oacute;N    <br>      ]]></body>
<body><![CDATA[<br>  <b>Keywords:</b>    <br>  &nbsp; &nbsp;ACUTE CORONARY SYNDROME    <br> &nbsp; &nbsp;REHABILITATION    <br> </font>     <p align="left"><font face="Verdana" size="2"> <b>I. Introducci&oacute;n&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> Los datos epidemiol&oacute;gicos muestran que la prevalencia de cardiopat&iacute;a isqu&eacute;mica  en nuestro pa&iacute;s va en descenso en los &uacute;ltimos a&ntilde;os, sin embargo contin&uacute;a  en el primer lugar entre las causas de muerte, junto al accidente cerebro-vascular</font><sup><font face="Verdana" size="2"><a name="-1"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  Los progresos en las t&eacute;cnicas de reperfusi&oacute;n y revascularizaci&oacute;n coronaria  han reducido la severidad y las complicaciones del s&iacute;ndrome coronario agudo  (SCA)</font><sup><font face="Verdana" size="2"><a name="-2"></a><a name="-3"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#2">2</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#3">3</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Pese a ello, el n&uacute;mero de pacientes discapacitados por esta  causa es sustancial, por lo que la prevenci&oacute;n secundaria cobra un papel  relevante en su rehabilitaci&oacute;n, buscando la disminuci&oacute;n de la morbimortalidad  y la mejor&iacute;a de la calidad de vida a largo plazo.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> La rehabilitaci&oacute;n cardiovascular (RC) ha sido definida como &ldquo;el programa  desarrollado por un equipo multidisciplinario de trabajo a largo plazo  que incluye la evaluaci&oacute;n m&eacute;dica, prescripci&oacute;n de ejercicio, modificaci&oacute;n  de los factores de riesgo cardiovascular, educaci&oacute;n y consejos m&eacute;dicos.  Est&aacute; designado para minimizar los efectos psicol&oacute;gicos y fisiol&oacute;gicos de  la enfermedad card&iacute;aca, reducir el riesgo de muerte s&uacute;bita o reinfarto,  control de los s&iacute;ntomas y reversi&oacute;n de los procesos ateroscler&oacute;ticos, mejorando  el estado psicosocial y ayudando al r&aacute;pido reintegro laboral&rdquo;</font><sup><font face="Verdana" size="2"><a name="-4"></a><a name="-5"></a><a name="-6"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#4">4-6</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Hay factores que determinan la evoluci&oacute;n y el pron&oacute;stico de los pacientes  que han sufrido un SCA: edad, comorbilidades, &aacute;rea de miocardio infartado,  funci&oacute;n ventricular, localizaci&oacute;n y extensi&oacute;n de la isquemia residual,  etc&eacute;tera<a name="-7"></a><a name="-8"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#7">7</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#8">8</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. El estado del miocardio afectado posevento va a determinar  las consecuencias funcionales en el futuro. La RC act&uacute;a para revertir,  en la medida de lo posible, los efectos delet&eacute;reos sobre sobre el sistema  cardiovascular, pero tambi&eacute;n tiene efecto beneficioso sobre el sistema  m&uacute;sculo-esquel&eacute;tico. El ejercicio programado act&uacute;a sobre la sarcopenia  que ocasiona el reposo, con p&eacute;rdida de fuerza muscular y disminuci&oacute;n de  la densidad de mineral &oacute;seo, de mayor magnitud en los pacientes revascularizados  quir&uacute;rgicamente y en los adultos mayores (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#fig_1">figura 1</a></font><font face="Verdana" size="2">)<a name="-9"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#9">9</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp;</font></p>         <p align="left"><font face="Verdana" size="2"><a name="fig_1"></a><img style="width: 330px; height: 317px;" alt="" src="/img/revistas/ruc/v29n1/1a19f1.JPG"> </font></p>           <p align="left"><font face="Verdana" size="2"> Despu&eacute;s que el paciente ha sido estabilizado se debe iniciar precozmente  un programa de RC coordinado por especialistas. El personal m&iacute;nimo involucrado  en primera instancia ser&aacute;: cardi&oacute;logo, enfermera, fisioterapeuta y nutricionista.  El objetivo inicial es la comprensi&oacute;n de la enfermedad coronaria, su aceptaci&oacute;n  y el inicio de su rehabilitaci&oacute;n, erradicando mitos y preconceptos. M&aacute;s  adelante nos referimos detalladamente a las condiciones necesarias para  un correcto manejo durante la internaci&oacute;n y luego del alta.&nbsp;&nbsp;</font></p>     ]]></body>
<body><![CDATA[<p align="left">&nbsp;</p>              <p align="left"><font face="Verdana" size="2"> <b>II. Efectos cardiovasculares del ejercicio f&iacute;sico&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> El objetivo de la actividad f&iacute;sica precoz es evitar la p&eacute;rdida de mecanismos  fisiol&oacute;gicos y bioqu&iacute;micos que se presentan r&aacute;pidamente con el reposo en  cama. El movimiento y una actividad f&iacute;sica reglada, acorde a cada paciente  y patolog&iacute;a, trae como primer efecto positivo un mantenimiento de la masa  y funci&oacute;n del ventr&iacute;culo izquierdo (VI), disminuci&oacute;n del estr&eacute;s oxidativo  producido por el da&ntilde;o celular y mejor&iacute;a de los mecanismos antioxidantes  del miocardio. El entrenamiento f&iacute;sico parece tener un efecto protector  contra la apoptosis card&iacute;aca, ya que modula genes relacionados con la muerte  celular<a name="-10"></a><a name="-11"></a><a name="-12"></a><a name="-13"></a><a name="-14"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#10">10-14</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>        <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> En los pacientes con insuficiencia card&iacute;aca la actividad f&iacute;sica mejora  el gasto card&iacute;aco, observ&aacute;ndose un efecto de remodelaci&oacute;n inversa del VI  con leves mejoras en la fracci&oacute;n de eyecci&oacute;n y reducciones en el di&aacute;metro  diast&oacute;lico final. Secundariamente, reduce la frecuencia card&iacute;aca en reposo  demostrando una disminuci&oacute;n del tono simp&aacute;tico. Esta reducci&oacute;n de catecolaminas  se acompa&ntilde;a de una disminuci&oacute;n de los niveles de angiotensina II, aldosterona  y factor natriur&eacute;tico auricular luego de algunas semanas de entrenamiento</font><sup><font face="Verdana" size="2"><a name="-15"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#15">15</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> La actividad f&iacute;sica mejora la disfunci&oacute;n endotelial coronaria al atenuar  la vasoconstricci&oacute;n arterial paradojal de los vasos epic&aacute;rdicos, efecto  que tambi&eacute;n se observa a nivel de las arterias perif&eacute;ricas</font><sup><font face="Verdana" size="2"><a name="-16"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#16">16</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> En los &uacute;ltimos a&ntilde;os se ha descrito tambi&eacute;n una mejor&iacute;a en la vasodilataci&oacute;n  de las arterias pulmonares. Es as&iacute; que la resistencia vascular pulmonar  disminuye luego de seis meses de entrenamiento<a name="-17"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#17">17</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.    <br>     &nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> <b>Beneficios asociados&nbsp;</b> </font></p>            <p><font face="Verdana" size="2"> La actividad f&iacute;sica regular modula la frecuencia card&iacute;aca (FC), consiguiendo  una disminuci&oacute;n de la basal, un menor incremento al esfuerzo, menor posibilidad  de alcanzar niveles de isquemia y aumento del umbral de aparici&oacute;n de arritmias  ventriculares, con menor actividad simpaticomim&eacute;tica<a name="-18"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#18">18</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. La FC elevada  est&aacute; asociada a mayor tasa de eventos adversos y su disminuci&oacute;n, a trav&eacute;s  del est&iacute;mulo parasimp&aacute;tico con el entrenamiento, minimiza la aparici&oacute;n  de estos</font><sup><font face="Verdana" size="2"><a name="-19"></a><a name="-20"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#19">19</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#20">20</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. El entrenamiento favorece tambi&eacute;n la r&aacute;pida recuperaci&oacute;n  de la FC posesfuerzo y cuanto m&aacute;s r&aacute;pida sea mejor ser&aacute; el pron&oacute;stico a  largo plazo. Lo deseable es un descenso de &sup3; 12 latidos en el primer minuto<a name="-21"></a><a name="-22"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#21">21</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#22">22</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  Tambi&eacute;n es muy conocido el efecto favorable del ejercicio aer&oacute;bico en la  regulaci&oacute;n de la presi&oacute;n arterial, reduciendo la sensibilidad a los beta  receptores y a los receptores colin&eacute;rgicos posejercicio, con una significativa  disminuci&oacute;n de la secreci&oacute;n de noradrenalina</font><sup><font face="Verdana" size="2"><a name="-23"></a><a name="-24"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#23">23</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#24">24</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. M&aacute;s discutido es el  desarrollo de capilares y circulaci&oacute;n colateral coronaria (observado en  estudios experimentales con animales)</font><sup><font face="Verdana" size="2"><a name="-25"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#25">25</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp;&nbsp;</font></p>         <p align="left"><font face="Verdana" size="2"> Tambi&eacute;n se producen efectos beneficiosos de la actividad f&iacute;sica a nivel  sist&eacute;mico sobre el metabolismo de la glucosa, de los l&iacute;pidos y del tejido  adiposo, en la funci&oacute;n del m&uacute;sculo esquel&eacute;tico, en la fuerza de los m&uacute;sculos  de la ventilaci&oacute;n, en la densidad &oacute;sea, en la coordinaci&oacute;n locomotora,  en el bienestar psicol&oacute;gico con mejor&iacute;a de los cuadros depresivos, todo  lo cual mejora la calidad de vida del paciente</font><sup><font face="Verdana" size="2"><a name="-26"></a><a name="-27"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#25">25-27</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">&nbsp;(</font><font color="#1f1a17" face="Verdana" size="2"><a href="/img/revistas/ruc/v29n1/1a19f2.JPG">figura 2</a></font><font face="Verdana" size="2">). </font></p>     <font face="Verdana" size="2">         ]]></body>
<body><![CDATA[<br>      </font>          <p align="left"><font face="Verdana" size="2"> <b>III. Seguridad y eficacia de la rehabilitaci&oacute;n cardiovascular&nbsp;</b></font></p>          <p align="left"><font face="Verdana" size="2"> <b>Seguridad&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> La RC es segura si se siguen las pautas establecidas con vigilancia estrecha  y respeto por los l&iacute;mites establecidos para cada paciente. No hay datos  de estudios aleatorizados recientes en cuanto a la tasa de complicaciones  graves, pero se reporta un evento no fatal (paro card&iacute;aco resucitado, infarto  de miocardio no fatal, arritmias ventriculares graves) cada 80.000 a 300.000  pacientes/hora de ejercicio y el riesgo de una muerte cada 300.000 a 780.000  pacientes/hora de ejercicio, entre enfermos coronarios no seleccionados<a name="-28"></a><a name="-29"></a><a name="-30"></a><a name="-31"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#28">28-31</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  De todas maneras, en los grupos supervisados esta posibilidad es muy infrecuente.  Hemos reportado recientemente que durante 13 a&ntilde;os de actividad de RC en  nuestra instituci&oacute;n, con m&aacute;s de 230.000 pacientes/hora de trabajo f&iacute;sico,  no han ocurrido muertes<a name="-32"></a><a name="-33"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#32">32</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#33">33</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp;</font></p>          <p align="left"><font face="Verdana" size="2"> <b>Eficacia&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> La RC ha demostrado eficacia en la mejor&iacute;a de la clase funcional, as&iacute; como  en reducci&oacute;n de nuevos eventos fatales y no fatales, lo que ha sido documentado  en numerosos estudios aleatorizados y metaan&aacute;lisis. Se ha demostrado una  mejor&iacute;a del consumo m&aacute;ximo de ox&iacute;geno (VO<sub>2m&aacute;x</sub>) promedio del 38% luego de  seis meses de entrenamiento<a name="-34"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#34">34</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> y una mejor&iacute;a del pico m&aacute;ximo de O<sub>2</sub> entre  11% a 37% (p&lt;0,001) obtenidos en pruebas de esfuerzo cardiopulmonar previos  y posteriores a per&iacute;odos de tres a seis meses de RC</font><sup><font face="Verdana" size="2"><a name="-35"></a><a name="-36"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#35">35</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#36">36</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>            <p><font face="Verdana" size="2"> En un estudio aleatorizado realizado por Hammill y colaboradores en 2010,  se demostr&oacute; una reducci&oacute;n de la mortalidad de 47% (HR 0,53; IC 95%, 0,48-0,59)  y una disminuci&oacute;n del riesgo relativo de infarto de 31% en aquellos pacientes  que hab&iacute;an asistido a 36 sesiones de RC comparados con los que solo hab&iacute;an  participado de una sesi&oacute;n (HR 0,69; IC 95%, 0,58-0,81)<a name="-37"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#37">37</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Un a&ntilde;o despu&eacute;s,  Lawler y colaboradores publicaron un metaan&aacute;lisis que incluy&oacute; 34 estudios  aleatorizados, con m&aacute;s de 6.000 pacientes sometidos a terapia f&iacute;sica, demostrando  una reducci&oacute;n significativa de la mortalidad global (HR 0,74, IC 95% 0,58-0,95),  de la muerte de causa card&iacute;aca (HR 0,64, IC 95% 0,46-0,88) y de nuevo infarto  no fatal (HR 0,53, IC 95% 0,38-0,76)</font><sup><font face="Verdana" size="2"><a name="-38"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#38">38</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Un estudio de la Cl&iacute;nica Mayo  analiz&oacute; en forma prospectiva, con seguimiento medio de 6,3 a&ntilde;os, a 2.395  pacientes consecutivos de una cohorte cerrada que hab&iacute;an sido sometidos  a angioplastia coronaria (ATC). Se compararon grupos que hab&iacute;an participado  de RC m&aacute;s de tres meses (40%) contra los que no lo hab&iacute;an hecho, demostrando  47% de reducci&oacute;n de la mortalidad global (HR 0,54, IC 95% 0,41-0,71, p&lt;0,001)  y 39% de reducci&oacute;n en mortalidad de causa card&iacute;aca (HR 0,69, IC 95% 0,41-0,91)<a name="-39"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#39">39</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  Suaya y colaboradores tambi&eacute;n reportaron, en un metaan&aacute;lisis de estudios  aleatorizados con cinco a&ntilde;os de seguimiento pos ATC (267.427 pacientes),  que la participaci&oacute;n en programas de RC se asociaba a una disminuci&oacute;n significativa  de las comorbilidades; hasta 28% de disminuci&oacute;n de la mortalidad global  y hasta 31% de reducci&oacute;n de la mortalidad card&iacute;aca, donde m&aacute;s de la mitad  de este beneficio era atribuible exclusivamente al ejercicio f&iacute;sico<a name="-40"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#40">40</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  En otro estudio de seguimiento a diez a&ntilde;os, Maroto Montero dividi&oacute; en forma  aleatoria dos grupos de pacientes posinfarto de miocardio, uno sometido  a RC versus otro de control y demostr&oacute; una reducci&oacute;n significativa (p=0,04)  de la mortalidad por todas las causas en el grupo de RC, con 91,8% de supervivencia  en dicho per&iacute;odo<a name="-41"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#41">41</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font>    </p>      <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> <b>Relaci&oacute;n costo-beneficio&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> La RC reduce reingresos hospitalarios, n&uacute;mero de consultas m&eacute;dicas o visitas  a servicios de urgencia, mejora los s&iacute;ntomas y disminuye la necesidad de medicamentos, todo lo cual condiciona una reducci&oacute;n de gastos al sistema  de salud. Asimismo, abate los costos derivados de ausencia laboral y los  gastos en pensiones por incapacidad</font><sup><font face="Verdana" size="2"><a name="-42"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#42">42</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.<sup>&nbsp;</sup> </font></p>          <p align="left"><font face="Verdana" size="2"> El costo-efectividad de una intervenci&oacute;n puede medirse en a&ntilde;os de vida  ganada contra el dinero gastado con la misma. Los trabajos de Oldridge,  y m&aacute;s tarde de Ades, establecieron que se consigue un ahorro significativo  con la RC, con mejor costo-efectividad que la terapia trombol&iacute;tica, la  ATC, la cirug&iacute;a de revascularizaci&oacute;n e incluso la medicaci&oacute;n para descender  el colesterol. Estos autores concluyen que si la totalidad de los candidatos  fueran incluidos en programas de RC se lograr&iacute;a abatir un 35% los gastos  en salud ocasionados por la enfermedad coronaria</font><sup><font face="Verdana" size="2"><a name="-43"></a><a name="-44"></a><a name="-45"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#43">43-45</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> La evidencia contundente a favor de la RC ha llevado a que las gu&iacute;as de  tratamiento posangioplastia la indiquen con un nivel de recomendaci&oacute;n I  (B) y ha sido incluida en la cobertura econ&oacute;mica realizada por los servicios  de Medicare y Medicaid en Estados Unidos<a name="-46"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#46">46</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp;</font></p>     <p align="left">&nbsp;</p>              <p align="left"><font face="Verdana" size="2"> <b>IV. Desarrollo de un programa de rehabilitaci&oacute;n cardiovascular&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> Luego del SCA, los pacientes deben ser incluidos r&aacute;pidamente en un programa  de RC, pues cuanto m&aacute;s precozmente se los involucre mayor ser&aacute; la adherencia  al tratamiento.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> La progresi&oacute;n de la RC en el enfermo que ha padecido un SCA se realiza  en cuatro fases sucesivas desde el diagn&oacute;stico hasta el alta alejada, seg&uacute;n  pautas de la American Association of Cardiovascular and Pulmonary Rehabilitation  (AACVPR)</font><sup><font face="Verdana" size="2"><a name="-47"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#47">47</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> y refrendadas para Sudam&eacute;rica en el Consenso de Rehabilitaci&oacute;n  Cardiovascular y Prevenci&oacute;n Secundaria de las Sociedades Interamericana  y Sudamericana de Cardiolog&iacute;a</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#31">31</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> <b>Fase I. Aguda u hospitalaria&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> Se extiende hasta el alta sanatorial y su duraci&oacute;n es variable seg&uacute;n el  tratamiento recibido, severidad del cuadro cl&iacute;nico y la evoluci&oacute;n. Cuando  se realiza solamente tratamiento m&eacute;dico o angioplastia, la internaci&oacute;n  de los pacientes de bajo riesgo dura promedialmente 3 d&iacute;as (1-5 d&iacute;as)<a name="-48"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#48">48</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  Cuando se practica cirug&iacute;a de revascularizaci&oacute;n en paciente no complicado  el promedio de internaci&oacute;n posoperatoria es de 6-7 d&iacute;as</font><sup><font face="Verdana" size="2"><a name="-49"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#49">49</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. En los casos  no quir&uacute;rgicos se comienza desde el primer d&iacute;a con movilizaci&oacute;n pasiva  precoz, adoptando la posici&oacute;n sentada al borde de la cama y ejercicios  de pies y piernas a cargo de fisioterapeutas entrenados. Si el paciente  se encuentra estable, a partir del segundo o tercer d&iacute;a puede caminar en  la habitaci&oacute;n algunos minutos dos veces al d&iacute;a, ba&ntilde;arse asistido y continuar  con ejercicios asistidos. Luego del tercer d&iacute;a puede sentarse en el sill&oacute;n,  levantarse al sanitario, caminar lentamente algunos minutos y realizar  ejercicios sin asistencia, supervisado por fisioterapeuta. Al cuarto d&iacute;a  se levanta libremente en su habitaci&oacute;n, se ba&ntilde;a solo, camina por el sector  dos veces al d&iacute;a y contin&uacute;a con ejercicios supervisados. En esta primera  fase se progresa lentamente consiguiendo un nivel de ejercicio de 2 a 3  Mets. En el paciente quir&uacute;rgico los tiempos son m&aacute;s lentos y dependen del  curso posoperatorio inmediato.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> En esta fase hospitalaria tiene una gran importancia la labor educativa  del paciente y su familia sobre la enfermedad coronaria, procedimientos  efectuados, cambios necesarios en el estilo de vida, alimentaci&oacute;n y medidas  de prevenci&oacute;n secundaria. Es el momento apropiado para comenzar el programa  de supresi&oacute;n tab&aacute;quica y ofrecer el apoyo psicol&oacute;gico y social que sea  necesario. Se deben brindar explicaciones detalladas sobre reinicio de  actividades laborales, vida sexual y actividad f&iacute;sica.&nbsp; </font></p>        <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> <b>Fase II. Inmediatamente luego del alta&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> La duraci&oacute;n promedio de esta fase es de 12 semanas. El plan de ejercicios  debe acompa&ntilde;arse de las medidas de prevenci&oacute;n secundaria que incluyen un  cambio en el estilo de vida, ajuste nutricional y medicaci&oacute;n adecuada a  cada caso.&nbsp; </font></p>          ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Lo m&aacute;s apropiado es llevar a cabo esta fase en un centro especializado  en RC. Los recursos humanos b&aacute;sicos de estas unidades son el cardi&oacute;logo,  m&eacute;dico deport&oacute;logo, fisioterapeuta, profesor de educaci&oacute;n f&iacute;sica, nutricionista,  psic&oacute;logo y asistente social. Todos los integrantes del equipo de RC que  trabajan en el gimnasio deben estar, por lo menos, entrenados en medidas  de soporte vital b&aacute;sico y el cardi&oacute;logo responsable de la sala en soporte  vital avanzado. Los grupos de pacientes deben tener un m&aacute;ximo de ocho a  diez asistentes.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Para la prescripci&oacute;n del plan de ejercicios, cada paciente debe ser evaluado  en su condici&oacute;n cl&iacute;nica y su situaci&oacute;n f&iacute;sica (Clase I, nivel de evidencia  A). Al inicio del programa, seg&uacute;n las caracter&iacute;sticas individuales, puede  realizarse una prueba ergom&eacute;trica limitada por los s&iacute;ntomas o un test de  caminata de 6 minutos (Clase I, C). Con ello se elabora un informe y se  estratifica el riesgo individual seg&uacute;n la clasificaci&oacute;n de la AACVPR, que  los clasifica en alto, moderado y bajo riesgo</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#47">47</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#tab_1">tabla 1</a></font><font face="Verdana" size="2">).</font></p>         <p align="left"><font face="Verdana" size="2"><a name="tab_1"></a><img style="width: 328px; height: 1051px;" alt="" src="/img/revistas/ruc/v29n1/1a19t1.JPG">&nbsp; </font> <font face="Verdana"><font size="2">    <br>      </font>      <basefont size="3"> </font> </p>           <p align="left"><font face="Verdana" size="2"> No hay acuerdo un&aacute;nime en cuanto a si todos los pacientes deben estar bajo  monitorizaci&oacute;n telem&eacute;trica en cada sesi&oacute;n de RC en las primeras 12 semanas  posevento</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#6">6</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#31">31</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Cuando ello es posible, la monitorizaci&oacute;n se propone para  todos, pero en los lugares donde no es f&aacute;cil contar con esta herramienta  es aceptable realizarlo solamente en los pacientes de riesgo alto. Si los  pacientes de riesgo moderado no son monitorizados, el cardi&oacute;logo debe estar  presente o disponible inmediatamente durante cada sesi&oacute;n de ejercicios.  Los pacientes clasificados en bajo riesgo pueden realizar actividad f&iacute;sica  con profesor de educaci&oacute;n f&iacute;sica o fisioterapeuta, sin supervisi&oacute;n m&eacute;dica  directa y permanente pues el riesgo de complicaciones es extremadamente  bajo</font><sup><font face="Verdana" size="2"><a name="-50"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#31">31</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#50">50</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> <i>Programa de entrenamiento f&iacute;sico&nbsp;</i> </font></p>          <p align="left"><font face="Verdana" size="2"> En este cap&iacute;tulo se tendr&aacute;n en cuenta cuatro variables: frecuencia semanal,  tipo de ejercicio, intensidad y duraci&oacute;n del programa.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> El entrenamiento f&iacute;sico comprende tres sesiones semanales de 60 a 80 minutos  de duraci&oacute;n efectuadas en el gimnasio del centro de RC. En cada sesi&oacute;n  se realiza un entrenamiento aer&oacute;bico en cinta o bicicleta ergom&eacute;trica m&aacute;s  una actividad de calistenia o gimnasia, con ejercicios de calentamiento  previo y enfriamiento posterior incluyendo los ejercicios de elongaci&oacute;n.  Inicialmente la actividad puede ser discontinua, con pausas seg&uacute;n la tolerancia,  para ir haci&eacute;ndola continua y de progresi&oacute;n gradual (variable de acuerdo  a la experiencia del entrenador).&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> La intensidad del esfuerzo se aplicar&aacute; seg&uacute;n f&oacute;rmulas. Una de ellas es  la frecuencia card&iacute;aca de entrenamiento (FCE). Se calcula de manera individual,  bas&aacute;ndose en los resultados de las pruebas de esfuerzo (si la hubiera)  o del test de caminata de 6 minutos. Si no existen signos cl&iacute;nicos o electrocardiogr&aacute;ficos  de isquemia, la FCE durante el primer mes ser&aacute; el 75% de la alcanzada en  los estudios funcionales y posteriormente llegar&aacute; a 85% (Clase I, C). En  los pacientes betabloqueados se sugiere, al inicio, no superar los 20 latidos  sobre la FC basal. Otra forma de regular la intensidad es trabajando con  una percepci&oacute;n del esfuerzo entre 11 y 14 de la escala de Borg (6 a 20).  Por encima del 85% de la FC m&aacute;xima (80% del VO<sub>2max</sub>), el riesgo de complicaciones  cardiovasculares aumenta significativamente. El consumo de energ&iacute;a ser&aacute;  de 1.500 a 2.000 kcal/semana (Clase I, B)</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#5">5</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><font size="2">.&nbsp;</font> </font></p>          <p align="left"><font face="Verdana" size="2"> Acorde a la evoluci&oacute;n, entre las cuatro y siete semanas posevento es aconsejable  realizar una prueba ergom&eacute;trica subm&aacute;xima o limitada por s&iacute;ntomas (no olvidar  que la mayor&iacute;a de esta poblaci&oacute;n est&aacute; betabloqueada), con lo que se podr&aacute;n  adaptar las cargas de trabajo y permitir&aacute; reestratificar al sujeto pudiendo  ser asignado a un grupo de menor riesgo</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#5">5</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Si alcanza 5 Mets sin s&iacute;ntomas  puede volver a su vida regular e incrementar la actividad f&iacute;sica. De lo  contrario trabajar&aacute; al 50% de su capacidad aer&oacute;bica m&aacute;xima (Clase I, C).  En pacientes con isquemia mioc&aacute;rdica residual debe mantenerse la FCE en  diez latidos por debajo del umbral de isquemia.&nbsp; </font></p>          ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Los ejercicios de fuerza o resistencia despu&eacute;s de un SCA han demostrado  ser muy eficientes, con baja tasa de complicaciones cuando se siguen las  normativas</font><sup><font face="Verdana" size="2"><a name="-51"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#51">51</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. En pacientes no quir&uacute;rgicos, de bajo o moderado riesgo,  se inician entre la segunda y la tercera semana de la fase II, con baja  carga, varias repeticiones, dos a tres veces por semana. En los pacientes  con cirug&iacute;a de revascularizaci&oacute;n, una vez estabilizados, se puede comenzar  con mancuernas y barra de pesas para miembros superiores luego de la sexta  a octava semana, manteniendo cargas por debajo de 4-5 kilos, con aumentos  lentos, progresivos, seg&uacute;n tolerancia. El trabajo de miembros inferiores  empieza tan pronto sea posible junto con los ejercicios aer&oacute;bicos. Estos  ejercicios pueden ser efectuados con el propio peso del paciente, bandas  el&aacute;sticas, poleas, pesas livianas, barras, y, cuando se disponga, de m&aacute;quinas  o circuitos de pesas. Este tipo de ejercicio no est&aacute; recomendado hasta  despu&eacute;s del tercer mes de la cirug&iacute;a y no deben ser realizados cuando el  paciente est&eacute; inestable cl&iacute;nicamente, con hipertensi&oacute;n arterial no controlada,  falla card&iacute;aca, arritmias complejas o valvulopat&iacute;as severas</font><sup><font face="Verdana" size="2"><a name="-52"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#51">51</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#52">52</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>           <p>  <multicol gutter="18" cols="2"></multicol> </p>         <p align="left"><font face="Verdana" size="2"> <i>Prevenci&oacute;n secundaria&nbsp;</i> </font></p>          <p align="left"><font face="Verdana" size="2"> En esta etapa todas las medidas de prevenci&oacute;n secundaria deben estar en  marcha. Debe evaluarse el &iacute;ndice de masa corporal y la composici&oacute;n corporal.  En los pacientes con sobrepeso u obesidad se demandar&aacute; la p&eacute;rdida de un  10% del peso corporal durante las fases I y II (Clase I, B). En este per&iacute;odo  es muy &uacute;til la detecci&oacute;n de apnea del sue&ntilde;o (Clase IIa, B). Se recomienda  alcanzar un per&iacute;metro abdominal &lt;102 cm en el hombre y &lt;88 cm en la mujer,  pero en los casos de alto riesgo y/o con m&uacute;ltiples factores de riesgo es  deseable lograr &lt;94 cm y &lt;80 cm en hombres y mujeres, respectivamente </font> <sup> <font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#5">5</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  Asimismo es fundamental el abordaje del tabaquismo (I, B), el screening  de depresi&oacute;n (I, B), control y regulaci&oacute;n de la presi&oacute;n arterial (I, B)  y adecuado manejo de la glicemia y los l&iacute;pidos sangu&iacute;neos (I, B), con indicaci&oacute;n  de estatinas para todos (I, A). Deben obtenerse datos de laboratorio posalta,  especialmente glicemia (HbA1c en diab&eacute;ticos), perfil lip&iacute;dico, e &iacute;ndices  de funcionamiento renal y hep&aacute;tico (I, B)</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#5">5</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Si no hay contraindicaciones se debe estimular a que el paciente realice  caminatas diarias, progresivas en duraci&oacute;n e intensidad, de acuerdo a las  semanas que lleva del alta. Al finalizar esta fase se deben repetir los  tests psico-f&iacute;sicos que se realizaron al inicio</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#31">31</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> <b>Fase III. De transici&oacute;n o mantenimiento precoz&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> Los pacientes que obtienen una mejor&iacute;a en la fase II y est&aacute;n asintom&aacute;ticos  pasan a la fase III donde se incrementa la intensidad de la actividad f&iacute;sica.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Se insiste en la optimizaci&oacute;n del control de los factores de riesgo, manteniendo  sesiones de actividad f&iacute;sica supervisada tres veces por semana m&aacute;s la actividad  extra que el paciente pueda realizar por su cuenta. Importa mantener y/o  incrementar la capacidad funcional y garantizar el bienestar psicol&oacute;gico.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Los pacientes ingresan en esta etapa con una capacidad funcional &sup3;6 Mets  en las pruebas de esfuerzo, ya saben controlar la intensidad del ejercicio  mediante la escala de Borg (13 a 15) y realizar el control de la frecuencia  card&iacute;aca. Los ejercicios de equilibrio cobran fundamental importancia en  esta etapa, sobre todo en adultos mayores, por lo que se recomienda practicarlos  dos a tres veces por semana. Duraci&oacute;n promedio de la fase 12 semanas.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> <b>Fase IV. Mantenimiento tard&iacute;o. Fase alejada&nbsp;</b> </font></p>          ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Los pacientes ingresan a esta fase cuando ya se han controlado los factores  de riesgo, han hecho cambios en su estilo de vida y han aprendido lo suficiente  sobre c&oacute;mo mantener su salud cardiovascular. Con la ayuda profesional,  ellos son los responsables de su progreso, de su bienestar psico-f&iacute;sico  y de la prevenci&oacute;n de reca&iacute;das aplicando todas las medidas aprendidas.  La actividad f&iacute;sica se realizar&aacute; una mayor cantidad de d&iacute;as en la semana  (cinco a siete) y se mantendr&aacute;n los planes nutricionales. Ya no est&aacute;n supervisados  por m&eacute;dico en las sesiones y se agregan otras actividades al aire libre  o bajo techo: caminatas, bicicleta, hidrogimnasia, trabajos de flexibilidad  y resistencia. En algunos casos se autoriza realizar juegos recreativos  no competitivos (volley, tenis, etc&eacute;tera). Esta actividad no debe ser inferior  en intensidad a 5 a 6 Mets.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Esta fase es de duraci&oacute;n indefinida, podemos decir que es para toda la  vida. Se deben lograr cambios permanentes en el estilo de vida apuntando  a lograr una mayor autoestima, retorno laboral precoz y reinserci&oacute;n social.  Asimismo se les recomienda mantener el contacto peri&oacute;dico con el cardi&oacute;logo  tratante y la pr&aacute;ctica de estudios pertinentes para un control adecuado.&nbsp; </font></p>     <font face="Verdana" size="2">         <br>      </font>          <p align="left"><font face="Verdana" size="2"> <b>V. Reintegro a la actividad&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> <b>Reintegro laboral&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> Si bien no es el objetivo de esta revisi&oacute;n, nos parece importante considerar  la vuelta al trabajo y/o a la actividad normal de un paciente que ha sufrido  un SCA. En este aspecto las gu&iacute;as proponen que luego de un evento no complicado,  sin injuria mioc&aacute;rdica, resuelto con ATC exitosa, asintom&aacute;tico, la vuelta  al trabajo puede realizarse pocos d&iacute;as despu&eacute;s del alta. Es importante  pesquisar posibles riesgos con el regreso al trabajo: esfuerzo, turnos,  factores ambientales, estr&eacute;s, riesgo para terceros, etc&eacute;tera</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#8">8</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> En el resto de los pacientes es imprescindible determinar el monto de injuria  del miocardio, reaparici&oacute;n de s&iacute;ntomas, arritmias y fundamentalmente la  capacidad funcional. La misma ser&aacute; evaluada por un test de caminata de  6 minutos o bien con una prueba ergom&eacute;trica, mientras que la funci&oacute;n ventricular  izquierda se evaluar&aacute; con un ecocardiograma Doppler. Los pacientes que  tienen funci&oacute;n sist&oacute;lica del VI normal, realizan un esfuerzo &gt;5 Mets en  la ergometr&iacute;a sin anormalidades cl&iacute;nicas ni electrocardiogr&aacute;ficas, est&aacute;n  aptos para todo trabajo. Los casos con tareas especialmente intensas (carga  de pesos, alba&ntilde;iler&iacute;a, etc&eacute;tera) deben ser considerados individualmente.  En cambio, los pacientes no quir&uacute;rgicos que tienen disfunci&oacute;n ventricular  izquierda significativa o isquemia en las pruebas funcionales pueden llevar  a cabo trabajos de oficina siempre que su capacidad de ejercicio sea &sup3;5  Mets</font><sup><font face="Verdana" size="2"><a name="-53"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#53">53</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> En los pacientes quir&uacute;rgicos se espera el alta del cirujano y que la esternotom&iacute;a  haya tenido buena cicatrizaci&oacute;n. En general, luego de los dos meses pueden  ser sometidos a la evaluaci&oacute;n antes mencionada.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> <b>Actividad sexual&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> Es muy com&uacute;n que los pacientes card&iacute;acos se enfrenten a problemas sexuales,  sobre todo impotencia, disminuci&oacute;n de la libido y trastornos de la eyaculaci&oacute;n.  La causa de estas dificultades puede estar en patolog&iacute;as asociadas (urol&oacute;gicas,  diabetes, etc&eacute;tera), edad avanzada, depresi&oacute;n, temor a precipitar un nuevo  evento, y pueden ser exacerbadas por la medicaci&oacute;n prescrita en prevenci&oacute;n  secundaria. El 5% de los episodios de angina de pecho, menos de 1% de los  infartos y 0,5% de las muertes s&uacute;bitas suceden durante el acto sexual.<b>  </b>Estos eventos son m&aacute;s frecuentes en aquellas personas sedentarias, con  enfermedad coronaria severa o con s&iacute;ntomas de angina a m&iacute;nimos esfuerzos  y en situaciones que se salen de la norma</font><sup><font face="Verdana" size="2"><a name="-54"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#54">54</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> En general se autorizan las relaciones sexuales luego de una a dos semanas  de un infarto no complicado, o incluso antes si se realiz&oacute; ATC exitosa  sin lesi&oacute;n mioc&aacute;rdica. En casos de cirug&iacute;a card&iacute;aca es mejor esperar entre  seis a ocho semanas para permitir un correcto cierre de la herida esternal.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Los pacientes con angina a peque&ntilde;os esfuerzos o m&iacute;nima actividad deber&iacute;an  abstenerse hasta haber estabilizado su situaci&oacute;n. En cambio, aquellos que  pueden caminar 15-20 cuadras a paso normal, o desarrollar m&aacute;s de 5 Mets  en la ergometr&iacute;a sin molestias, est&aacute;n en condiciones de mantener relaciones  sexuales. Los pacientes deben reportar cualquier s&iacute;ntoma adverso al m&eacute;dico  o a un miembro del equipo de RC</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#54">54</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Es razonable considerar el tratamiento  farmacol&oacute;gico de la disfunci&oacute;n er&eacute;ctil en cada caso, con el uso de sildenafil  o tadalafil siempre que no est&eacute;n recibiendo nitratos.&nbsp; </font></p>          <p align="left"><font face="Verdana" size="2"> Todos los aspectos pr&aacute;cticos del retorno a una vida normal pueden manejarse  mejor en charlas y reuniones grupales, incluso con la participaci&oacute;n de  familiares. Ello aumenta la adherencia al tratamiento m&eacute;dico farmacol&oacute;gico,  la modificaci&oacute;n de estilos de vida y al cumplimiento de chequeos peri&oacute;dicos  (cl&iacute;nicos, an&aacute;lisis de laboratorio y otros estudios). Nuestra experiencia  y la de otros grupos de nuestro medio han sido exitosas en ese aspecto</font><sup><font face="Verdana" size="2"><a name="-55"></a><a name="-56"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#55">55</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#56">56</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>     <font face="Verdana" size="2">         <br>      </font>          <p align="left"><font face="Verdana" size="2"> <b>VI. Expectativas de la rehabilitaci&oacute;n cardiovascular&nbsp;</b> </font></p>          <p align="left"><font face="Verdana" size="2"> Las expectativas de la RC son la mejor&iacute;a de la calidad de vida del paciente,  la disminuci&oacute;n de la morbimortalidad cardiovascular y global, el acortamiento  de los plazos de reintegro laboral y social, la disminuci&oacute;n de costos por  invalidez, reinternaciones y nuevos procedimientos invasivos. Hay que recordar  que la mejor&iacute;a conseguida con el entrenamiento f&iacute;sico puede ser alcanzada  por los enfermos coronarios, con independencia del tama&ntilde;o del infarto o  de la severidad de la disfunci&oacute;n ventricular. Se debe dar mayor divulgaci&oacute;n  de los beneficios de la RC, estimular su desarrollo y la participaci&oacute;n  en estos programas. En nuestro pa&iacute;s la tasa de abandonos de los programas  de RC es cercana al 50% a los seis meses y para algunos autores alcanza  70%-80% al a&ntilde;o<a name="-57"></a></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#57">57</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.<sup> </sup>Es preocupante el escaso conocimiento y derivaci&oacute;n  a estos programas por parte de los m&eacute;dicos y la m&iacute;nima participaci&oacute;n por  parte de los pacientes. En diferentes pa&iacute;ses el porcentaje de inclusi&oacute;n  en programas de RC es muy variable, en Estados Unidos es cercano a 20%,  mientras que en el conjunto de Latinoam&eacute;rica es inferior a 10% y en nuestro  pa&iacute;s ronda el 4%</font><sup><font face="Verdana" size="2"><a name="-58"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#58">58</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><font size="2">.&nbsp;</font> </font></p>          <p align="left"><font face="Verdana" size="2"> Para obtener la mejor&iacute;a esperada en los pacientes y lograr el impacto deseado  en la sociedad, la prevenci&oacute;n secundaria y la RC deben convertirse en herramientas  prioritarias en el manejo de la enfermedad coronaria. Es necesario educar  sobre los beneficios de la RC y eliminar las barreras que dificultan su  implementaci&oacute;n, integr&aacute;ndola entre las prestaciones obligatorias de nuestro  sistema de salud asegurando de ese modo su financiamiento. De lo contrario  corremos el riesgo &ldquo;de perder el barco y la oportunidad de ayudar debidamente  y a tiempo a nuestros pacientes&rdquo;, como afirma el Dr. Randal Thomas, Past-President  de la AACVPR</font><sup><font face="Verdana" size="2"><a name="-59"></a>(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#59">59</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp;</font></p>         <p align="left">&nbsp;</p>     <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> <b>Bibliograf&iacute;a&nbsp;</b> </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="1"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#-1">1</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Comisi&oacute;n Honoraria para la Salud Cardiovascular, &Aacute;rea Epidemiolog&iacute;a y  Estad&iacute;stica.</b> Mortalidad por enfermedades cardiovasculares en el Uruguay  2010. Montevideo: CHSC, 2010. Obtenido de: </font><font color="#1f1a17" face="Verdana" size="2"> <a href="http://www.cardiosalud.org/files/documents/mortalidad-2010.pdf">http://www.cardiosalud.org/files/documents/mortalidad-2010.pdf</a></font><font face="Verdana" size="2">.  [Consulta: 10 mar. 2014].    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332527&pid=S1688-0420201400010001900001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="2"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#-2">2</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, et  al; FIR Collaboration.</b> Long-term outcome of a routine versus selective  invasive strategy in patients with non-ST-segment elevation acute coronary  syndrome a meta-analysis of individual patient data. J Am Coll Cardiol  2010; 55(22):2435-45.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332529&pid=S1688-0420201400010001900002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="3"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#-3">3</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Briffa T, Hickling S, Knuiman M, Hobbs M, Hung J, Sanfilippo FM, et al.  </b>Long term survival after evidence based treatment of acute myocardial infarction  and revascularisation: follow-up of population based Perth MONICA cohort,  1984-2005. BMJ 2009; 338:b36.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332531&pid=S1688-0420201400010001900003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="4"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#-4">4</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al;  American Heart Association Exercise, Cardiac Rehabilitation, and Prevention  Committee, the Council on Clinical Cardiology; American Heart Association  Council on Cardiovascular Nursing; American Heart Association Council on  Epidemiology and Prevention; American Heart Association Council on Nutrition,  Physical Activity, and Metabolism; American Association of Cardiovascular  and Pulmonary Rehabilitation.</b> Core components of cardiac rehabilitation/secondary  prevention programs: 2007 update: a scientific statement from the American  Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee,  the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing,  Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism;  and the American Association of Cardiovascular and Pulmonary Rehabilitation.  Circulation 2007; 115(20):2675-82.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332533&pid=S1688-0420201400010001900004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="5"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#-5">5</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Piepoli MF, Corr&agrave; U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita  D, et al; Cardiac Rehabilitation Section of the European Association of  Cardiovascular Prevention and Rehabilitation.</b> Secondary prevention through  cardiac rehabilitation: from knowledge to implementation. A position paper  from the Cardiac Rehabilitation Section of the European Association of  Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil  2010; 17(1):1-17.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332535&pid=S1688-0420201400010001900005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="6"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#-6">6</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Thomas RJ, King M, Lui K, Oldridge N, Pi&ntilde;a IL, Spertus J; American Association  of Cardiovascular and Pulmonary Rehabilitation/American College of Cardiology/American  Heart Association Cardiac Rehabilitation/Secondary Prevention Performance  Measures Writing Committee. </b>AACVPR/ACC/AHA 2007 performance measures on  cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary  prevention services. Circulation 2007; 116(14):1611-42.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332537&pid=S1688-0420201400010001900006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="7"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-7"> 7</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. </b>Clinical practice  guidelines and quality of care for older patients with multiple comorbid  diseases: implications for pay for performance. JAMA 2005; 294(6):716-24.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332539&pid=S1688-0420201400010001900007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->  &nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="8"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-8"> 8</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute  Coronary Syndromes of European Society of Cardiology. </b>Guidelines for the  diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.  Eur Heart J 2007; 28(13):1598-660.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332541&pid=S1688-0420201400010001900008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="9"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#-9">9</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Braith RW, Stewart KJ.</b> Resistance exercise training: its role in the  prevention of cardiovascular disease. Circulation 2006; 113(22):2642-50.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332543&pid=S1688-0420201400010001900009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="10"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-10">10</a></font><font face="Verdana" size="2">.<b>&nbsp;&nbsp;&nbsp;&nbsp;Gielen S, Schuler G, Adams V.</b> Cardiovascular effects of exercise training:  molecular mechanisms. Circulation 2010; 122(12):1221-38.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332545&pid=S1688-0420201400010001900010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="11"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-11">11</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Dorfman TA, Levine BD, Tillery T, Peshock RM, Hastings JL, Schneider  SM, et al.</b> Cardiac atrophy in women following bed rest. J Appl Physiol  (1985) 2007; 103(1):8-16.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332547&pid=S1688-0420201400010001900011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="12"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-12">12</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Hambrecht R, Adams V, Erbs S, Linke A, Kr&auml;nkel N, Shu Y, Baither et  al.</b> Regular physical activity improves endothelial function in patients  with coronary artery disease by increasing phosphorylation of endothelial  nitric oxide synthase. Circulation 2003; 107(25):3152-8.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332549&pid=S1688-0420201400010001900012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="13"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-13">13</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Wassmann S, Wassmann K, Nickenig G. </b>Modulation of oxidant and antioxidant  enzyme expression and function in vascular cells. Hypertension 2004; 44(4):381-6.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332551&pid=S1688-0420201400010001900013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="14"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-14">14</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Adams V, Linke A, Kr&auml;nkel N, Erbs S, Gielen S, M&ouml;bius-Winkler S, et  al.</b> Impact of regular physical activity on the NAD(P)H oxidase and angiotensin  receptor system in patients with coronary artery disease. Circulation 2005;  111(5):555-62.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332553&pid=S1688-0420201400010001900014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="15"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-15">15</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Vona M, Codeluppi GM, Iannino T, Ferrari E, Bogousslavsky J, von Segesser  LK.</b> Effects of different types of exercise training followed by detraining  on endothelium-dependent dilation in patients with recent myocardial infarction.  Circulation 2009; 119(12):1601-8.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332555&pid=S1688-0420201400010001900015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="16"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-16">16</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al.</b> Effects  of exercise training on left ventricular function and peripheral resistance  in patients with chronic heart failure: A randomized trial. JAMA 2000;  283(23):3095-101.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332557&pid=S1688-0420201400010001900016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <multicol gutter="18" cols="2"></multicol>     <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="17"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-17">17</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, et  al. </b>Exercise and respiratory training improve exercise capacity and quality  of life in patients with severe chronic pulmonary hypertension. Circulation  2006; 114(14):1482-9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332559&pid=S1688-0420201400010001900017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="18"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-18">18</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Malfatto G, Blengino S, Annoni L, Branzi G, Bizzi C, Facchini M. </b>Original  articles primary coronary angioplasty and subsequent cardiovascular rehabilitation  are linked to a favorable sympathovagal balance after a first anterior  myocardial infarction. Ital Heart J 2005; 6(1):21-7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332561&pid=S1688-0420201400010001900018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="19"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-19">19</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Hull SS Jr, Vanoli E, Adamson PB, Verrier RL, Foreman RD, Schwartz PJ.</b>  Exercise training confers anticipatory protection from sudden death during  acute myocardial ischemia. Circulation 1994; 89(2):548-52.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332563&pid=S1688-0420201400010001900019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="20"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-20">20</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Lucini D, Milani RV, Costantino G, Lavie CJ, Porta A, Pagani M.</b> Effects  of cardiac rehabilitation and exercise training on autonomic regulation  in patients with coronary artery disease. Am Heart J 2002; 143(6):977-83.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332565&pid=S1688-0420201400010001900020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="21"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-21">21</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS.</b> Heart-rate  recovery immediately after exercise as a predictor of mortality. N Engl  J Med 1999; 341(18):1351-7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332567&pid=S1688-0420201400010001900021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="22"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-22">22</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Myers J, Tan SY, Abella J, Aleti V, Froelicher VF. </b>Comparison of the  chronotropic response to exercise and heart rate recovery in predicting  cardiovascular mortality. Eur J Cardiovasc Prev Rehabil 2007; 14(2):215-21.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332569&pid=S1688-0420201400010001900022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="23"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-23">23</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B&ouml;hm M, et al.</b>  2013 ESH/ESC guidelines for the management of arterial hypertension: the  Task Force for the Management of Arterial Hypertension of the European  Society of Hypertension (ESH) and of the European Society of Cardiology  (ESC). Eur Heart J 2013; 34(28):2159-219.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332571&pid=S1688-0420201400010001900023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="24"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-24">24</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Molmen-Hansen HE, Stolen T, Tjonna AE, Aamot IL, Ekeberg IS, Tyldum  GA, et al.</b> Aerobic interval training reduces blood pressure and improves  myocardial function in hypertensive patients. Eur J Prev Cardiol 2012;  19(2):151-60.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332573&pid=S1688-0420201400010001900024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="25"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-25">25</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Schuler G, Adams V, Goto Y.</b> Role of exercise in the prevention of cardiovascular  disease: results, mechanisms, and new perspectives. Eur Heart J 2013; 34(24):1790-9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332575&pid=S1688-0420201400010001900025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="26"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-26">26</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Bettencourt N, Dias C, Mateus P, Sampaio F, Santos L, Adao L, et al.</b>  Impacto da rehabilita&ccedil;ao card&iacute;aca na qualidade de vida e sintomatolog&iacute;a  depressiva ap&oacute;s s&iacute;ndrome coronaria aguda. Rev Port Cardiol 2005; 24(5):687-96.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332577&pid=S1688-0420201400010001900026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="27"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-27">27</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann  PG, Lesp&eacute;rance F, et al; American Heart Association Prevention Committee  of the Council on Cardiovascular Nursing; American Heart Association Council  on Clinical Cardiology; American Heart Association Council on Epidemiology  and Prevention; American Heart Association Interdisciplinary Council on  Quality of Care and Outcomes Research; American Psychiatric Association.</b>  Depression and coronary heart disease: recommendations for screening, referral,  and treatment: a science advisory from the American Heart Association Prevention  Committee of the Council on Cardiovascular Nursing, Council on Clinical  Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary  Council on Quality of Care and Outcomes Research: endorsed by the American  Psychiatric Association. Circulation 2008; 118(17):1768-75.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332579&pid=S1688-0420201400010001900027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="28"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-28">28</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Franklin BA, Bonzheim K, Gordon S, Timmis GC.</b> Safety of medically supervised  outpatient cardiac rehabilitation exercise therapy: a 16-year follow-up.  Chest 1998; 114(3):902-6.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332581&pid=S1688-0420201400010001900028&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="29"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-29">29</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Van Camp SP, Peterson RA.</b> Cardiovascular complications of outpatient  cardiac rehabilitation programs. JAMA 1986; 256(9):1160-3.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332583&pid=S1688-0420201400010001900029&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="30"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-30">30</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, et al;  American Heart Association; Council on Clinical Cardiology (Subcommittee  on Exercise, Cardiac Rehabilitation, and Prevention); Council on Nutrition,  Physical Activity, and Metabolism (Subcommittee on Physical Activity);  American association of Cardiovascular and Pulmonary Rehabilitation.</b> Cardiac  rehabilitation and secondary prevention of coronary heart disease: an American  Heart Association scientific statement from the Council on Clinical Cardiology  (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and  the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee  on Physical Activity), in collaboration with the American association of  Cardiovascular and Pulmonary Rehabilitation. Circulation 2005; 111(3):369-76.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332585&pid=S1688-0420201400010001900030&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="31"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-31">31</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>L&oacute;pez Jim&eacute;nez F, P&eacute;rez &nbsp;Terzic C, Zeballos PC, Anchique CV, Burdiat  G, Gonz&aacute;lez K, et al.</b> Consenso de Rehabilitaci&oacute;n Cardiovascular y Prevenci&oacute;n  Secundaria de las Sociedades Interamericana y Sudamericana de Cardiolog&iacute;a.  Rev Urug Cardiol 2013; 28(2):189-224.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332587&pid=S1688-0420201400010001900031&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="32"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-32">32</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Burdiat G, Lucini G, Rienzi E.</b> Incidencia de efectos adversos mayores  durante un programa de rehabilitaci&oacute;n card&iacute;aca: tema Libre del 28&ordm; Congreso  Uruguayo de Cardiolog&iacute;a. Rev Urug Cardiol 2012; Supl 1: S48-9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332589&pid=S1688-0420201400010001900032&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="33"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-33">33</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Burdiat Rampa G.</b> Seguridad y eficacia de un programa de rehabilitaci&oacute;n  card&iacute;aca en pacientes de alto riesgo en un medio hospitalario. Rev Urug  Cardiol 2008; 23(2):150-6.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332591&pid=S1688-0420201400010001900033&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>           <p>  <multicol gutter="18" cols="2"></multicol> </p>         <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="34"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-34">34</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Burdiat G, Lucini G, Rienzi E.</b> Mejor&iacute;a de la capacidad funcional de  distintas poblaciones de pacientes coronarios sometidos a un programa de  rehabilitaci&oacute;n card&iacute;aca: tema Libre del 28&ordm; Congreso Uruguayo de Cardiolog&iacute;a.  Rev Urug Cardiol 2012; Supl 1: S47-8.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332594&pid=S1688-0420201400010001900034&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="35"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-35">35</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, et al.</b>  Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation.  Circulation 2002; 106(6):666-71.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332596&pid=S1688-0420201400010001900035&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="36"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-36">36</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Ades PA, Savage PD, Brawner CA, Lyon CE, Ehrman JK, Bunn JY, et al.</b>  Aerobic capacity in patients entering cardiac rehabilitation. Circulation  2006; 113(23):2706-12.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332598&pid=S1688-0420201400010001900036&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="37"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-37">37</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Hammill BG, Curtis LH, Schulman KA, Whellan DJ. </b>Relationship between  cardiac rehabilitation and long-term risks of death and myocardial infarction  among elderly Medicare beneficiaries. Circulation 2010; 121(1):63-70.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332600&pid=S1688-0420201400010001900037&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="38"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-38">38</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Lawler PR, Filion KB, Eisenberg MJ.</b> Efficacy of exercise-based cardiac  rehabilitation post-myocardial infarction: a systematic review and meta-analysis  of randomized controlled trials. Am Heart J 2011; 162(4):571-584.e2&nbsp;    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332602&pid=S1688-0420201400010001900038&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="39"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-39">39</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. </b>Impact of cardiac  rehabilitation on mortality and cardiovascular events after percutaneous  coronary intervention in the community. Circulation 2011; 123(21):2344-52.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332604&pid=S1688-0420201400010001900039&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="40"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-40">40</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS. </b>Cardiac rehabilitation  and survival in older coronary patients. J Am Coll Cardiol 2009; 54(1):25-33.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332606&pid=S1688-0420201400010001900040&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="41"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-41">41</a></font><font face="Verdana" size="2">.<b>&nbsp;&nbsp;&nbsp;&nbsp;Maroto Montero JM, Artigao Ram&iacute;rez R, Morales Dur&aacute;n, de Pablo Zarzosa  C, &nbsp;Abraira V.</b> Rehabilitaci&oacute;n card&iacute;aca en pacientes con infarto de miocardio:  resultados tras 10 a&ntilde;os de seguimiento. Rev Esp Cardiol 2005; 58(10): 1181-7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332608&pid=S1688-0420201400010001900041&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="42"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-42">42</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Oldridge N, Furlong W, Feeny D, Torrance G, Guyatt G, Crowe J, et al.  </b>Economic evaluation of cardiac rehabilitation soon after acute myocardial  infarction. Am J Cardiol 1993; 72(2):154-61.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332610&pid=S1688-0420201400010001900042&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="43"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-43">43</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Ades PA, Huang D, Weaver SO. </b>Cardiac rehabilitation participation predicts  lower rehospitalization costs. Am Heart J 1992; 123(4 Pt 1):916-21.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332612&pid=S1688-0420201400010001900043&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="44"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-44">44</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Ades PA, Pashkow FJ, Nestor JR.</b> Cost-effectiveness of cardiac rehabilitation  after myocardial infarction. J Cardiopulm Rehabil 1997; 17(4):222-31.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332614&pid=S1688-0420201400010001900044&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="45"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-45">45</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Briffa TG, Eckermann SD, Griffiths AD, Harris PJ, Heath MR, Freedman  SB, et al.</b> Cost-effectiveness of rehabilitation after an acute coronary  event: a randomised controlled trial. Med J Aust 2005; 183(9):450-5.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332616&pid=S1688-0420201400010001900045&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="46"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-46">46</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Centers for Medicare and Medicaid Services.</b> Decision Memo for Cardiac  Rehabilitation Programs (CAG-00089R). Baltimore: CMS, 2006. Disponible  en: </font><font color="#1f1a17" face="Verdana" size="2"> <a href="http://www.cms.gov">http://www.cms.gov</a></font><font face="Verdana" size="2">/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=164&amp;NcaName=Cardiac+Rehabilitation+Programs&amp;NCDId=36&amp;ncdver=1&amp;IsPopup=y&amp;bc=AAAAAA AACAAAAA%3D%3D&amp;. [Consulta: 10 mar. 2014].    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332618&pid=S1688-0420201400010001900046&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="47"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-47">47</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>American Association for Cardiovascular and Pulmonary Rehabilitation.</b>  Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs.  4 ed. Champaign, Illinois: Human Kinetics Publishers; 2004.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332620&pid=S1688-0420201400010001900047&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="48"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-48">48</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Steg G, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al.  </b>Gu&iacute;a de pr&aacute;ctica cl&iacute;nica de la ESC para el manejo del infarto agudo de  miocardio en pacientes con elevaci&oacute;n del segmento ST. Rev Esp Cardiol 2013;  66(1): 53.e1-e46.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332622&pid=S1688-0420201400010001900048&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="49"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-49">49</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Alonso JJ, Azpitarte J, Bardaj&iacute; A, Cabad&eacute;s A, Fern&aacute;ndez A, Palencia  M, et al. </b>Gu&iacute;as de pr&aacute;ctica cl&iacute;nica de la Sociedad Espa&ntilde;ola de Cardiolog&iacute;a  en cirug&iacute;a coronaria. Rev Esp Cardiol 2000; 53(2):241-66.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332624&pid=S1688-0420201400010001900049&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="50"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-50">50</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Espinoza Caliani S, Bravo Navas JC, G&oacute;mez Doblas JJ, Collantes Rivera  R, Gonz&aacute;lez Jim&eacute;nez B, Mart&iacute;nez Lao, et al. </b>Rehabilitaci&oacute;n card&iacute;aca postinfarto  de miocardio en enfermos de bajo riesgo. Resultados de un programa de coordinaci&oacute;n  entre cardiolog&iacute;a y atenci&oacute;n primaria. Rev Esp Cardiol 2004; 57(1): 53-9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332626&pid=S1688-0420201400010001900050&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->  &nbsp; </font></p>          ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="51"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-51">51</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Pollock ML, Franklin BA, Balady GJ, Chaitman BL, Fleg JL, Fletcher B,  et al. </b>AHA Science Advisory. Resistance exercise in individuals with and  without cardiovascular disease: benefits, rationale, safety, and prescription:  An advisory from the Committee on Exercise, Rehabilitation, and Prevention,  Council on Clinical Cardiology, American Heart Association; Position paper  endorsed by the American College of Sports Medicine. Circulation 2000;  101(7):828-33.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332628&pid=S1688-0420201400010001900051&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="52"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-52">52</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Ehlke K, Greenwood M. </b>Resistance Exercise for Post-Myocardial Infarction  Patients: Current Guidelines and Future Considerations. Strength Cond J  2006; 28(6):56-62.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332630&pid=S1688-0420201400010001900052&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>              <!-- ref --><p><font face="Verdana" size="2"><a name="53"></a></font><font color="#1f1a17" face="Verdana" size="2"><a href="#-53">53</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Grima A, Alegr&iacute;a-Ezquerra E.</b> Reporting on coronary patients for returning  to work: an algorithm. ESC Councils. Council for Cardiology Practice. E-J  Cardiol Pract 2012; Vol 10(20). Disponible en: </font><font color="#1f1a17" face="Verdana" size="2"> <a href="http://www.escardio.org">http://www.escardio.org</a></font><font face="Verdana" size="2">/communities/councils/ccp/e-journal/volume10/Pages/cardiovascular-risk-functional-capacity-coronary-patients-return-to-work-  Grima-Alberto-Alegr%C3%ADa-Eduardo.aspx#.UzmfSM4hFEc. [Consulta: 5 oct.  2013].    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332632&pid=S1688-0420201400010001900053&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp;&nbsp;</font></p>      <multicol gutter="18" cols="2"></multicol>     <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="54"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-54">54</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB,  et al; American Heart Association Council on Clinical Cardiology; Council  on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia;  Council on Quality of Care and Outcomes Research. </b>Sexual activity and cardiovascular  disease: a scientific statement from the American Heart Association. Circulation  2012; 125(8):1058-72.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332634&pid=S1688-0420201400010001900054&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="55"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-55">55</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Tejada J, V&aacute;zquez H, Burdiat G, Sandoya E, Prendez D, Criado N, et al.</b>  Evaluaci&oacute;n de una actividad educativa al alta de pacientes coronarios:  tema Libre del 27&ordm; Congreso Uruguayo de Cardiolog&iacute;a. Rev Urug Cardiol 2011;  Supl 1: S73.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332636&pid=S1688-0420201400010001900055&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="56"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-56">56</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Gambogi R, Baldizzoni M, Albornoz H, Ketzoian C, Cabrera M, Saona G,  et al.</b> Prevenci&oacute;n secundaria en pacientes revascularizados coronarios en  Uruguay: descripci&oacute;n de un programa, evaluaci&oacute;n del control de los factores  de riesgo y efectos en la mortalidad. Cl&iacute;n Investg Arterioscler 2010; 22(2):  59-69.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332638&pid=S1688-0420201400010001900056&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="57"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-57">57</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Carlson JJ, Norman GJ, Feltz DL, Franklin BA, Johnson JA, Locke SK.  </b>Self-efficacy, psychosocial factors, and exercise behavior in traditional  versus modified cardiac rehabilitation. J Cardiopulm Rehabil 2001; 21(6):363-73.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332640&pid=S1688-0420201400010001900057&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="58"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-58">58</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Burdiat G, P&eacute;rez Terzic C, L&oacute;pez Jim&eacute;nez F, Cortes Bergoderi M, Santib&aacute;&ntilde;ez  C.</b> Situaci&oacute;n actual de la rehabilitaci&oacute;n card&iacute;aca en Uruguay. Rev Urug  Cardiol 2011; 26(1):40-7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332642&pid=S1688-0420201400010001900058&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>          <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="59"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#-59">59</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Thomas RJ.</b> Cardiac rehabilitation/secondary prevention programs: a raft  for the rapids: why have we missed the boat? Circulation 2007; 116(15):1644-6.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=332644&pid=S1688-0420201400010001900059&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref -->&nbsp; </font></p>           <p>  </p>          ]]></body>
<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Comisión Honoraria para la Salud Cardiovascular^dÁrea Epidemiología y Estadística</collab>
<source><![CDATA[Mortalidad por enfermedades cardiovasculares en el Uruguay 2010]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[CHSC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fox]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Clayton]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Damman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pocock]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[de Winter]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tijssen]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2010</year>
<volume>55</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>2435-45</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Briffa]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hickling]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Knuiman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hobbs]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hung]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sanfilippo]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2009</year>
<volume>338</volume>
<page-range>b36</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balady]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Ades]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Bittner]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Comoss]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Foody]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2007</year>
<volume>115</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>2675-82</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piepoli]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Corrà]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Benzer]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Bjarnason-Wehrens]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Dendale]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gaita]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Secondary prevention through cardiac rehabilitation: from knowledge to implementation: A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation]]></article-title>
<source><![CDATA[Eur J Cardiovasc Prev Rehabil]]></source>
<year>2010</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-17</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lui]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Oldridge]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Piña]]></surname>
<given-names><![CDATA[IL]]></given-names>
</name>
<name>
<surname><![CDATA[Spertus]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2007</year>
<volume>116</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1611-42</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyd]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Darer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Boult]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fried]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
<name>
<surname><![CDATA[Boult]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2005</year>
<volume>294</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>716-24</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>European Society of Cardiology^dTask Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes</collab>
<article-title xml:lang="en"><![CDATA[Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2007</year>
<volume>28</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1598-660</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braith]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Resistance exercise training: its role in the prevention of cardiovascular disease]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2006</year>
<volume>113</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>2642-50</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gielen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Schuler]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiovascular effects of exercise training: molecular mechanisms]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2010</year>
<volume>122</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1221-38</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dorfman]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Tillery]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Peshock]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Hastings]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiac atrophy in women following bed rest]]></article-title>
<source><![CDATA[J Appl Physiol (1985)]]></source>
<year>2007</year>
<volume>103</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-16</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hambrecht]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Erbs]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Linke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kränkel]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Shu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Baither]]></surname>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2003</year>
<volume>107</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>3152-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wassmann]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wassmann]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Nickenig]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Modulation of oxidant and antioxidant enzyme expression and function in vascular cells]]></article-title>
<source><![CDATA[Hypertension]]></source>
<year>2004</year>
<volume>44</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>381-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Linke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kränkel]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Erbs]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gielen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Möbius-Winkler]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2005</year>
<volume>111</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>555-62</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vona]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Codeluppi]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Iannino]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrari]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bogousslavsky]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[von Segesser]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effects of different types of exercise training followed by detraining on endothelium-dependent dilation in patients with recent myocardial infarction]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2009</year>
<volume>119</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1601-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hambrecht]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gielen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Linke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fiehn]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Walther]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2000</year>
<volume>283</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>3095-101</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mereles]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ehlken]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kreuscher]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ghofrani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hoeper]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Halank]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2006</year>
<volume>114</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1482-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malfatto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Blengino]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Annoni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Branzi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bizzi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Facchini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Original articles primary coronary angioplasty and subsequent cardiovascular rehabilitation are linked to a favorable sympathovagal balance after a first anterior myocardial infarction]]></article-title>
<source><![CDATA[Ital Heart J]]></source>
<year>2005</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-7</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hull]]></surname>
<given-names><![CDATA[SS Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Vanoli]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Adamson]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
<name>
<surname><![CDATA[Verrier]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Foreman]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1994</year>
<volume>89</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>548-52</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lucini]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Milani]]></surname>
<given-names><![CDATA[RV]]></given-names>
</name>
<name>
<surname><![CDATA[Costantino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lavie]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Porta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pagani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>2002</year>
<volume>143</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>977-83</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cole]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Blackstone]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
<name>
<surname><![CDATA[Pashkow]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Snader]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Lauer]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Heart-rate recovery immediately after exercise as a predictor of mortality]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1999</year>
<volume>341</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>1351-7</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Abella]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Aleti]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Froelicher]]></surname>
<given-names><![CDATA[VF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of the chronotropic response to exercise and heart rate recovery in predicting cardiovascular mortality]]></article-title>
<source><![CDATA[Eur J Cardiovasc Prev Rehabil]]></source>
<year>2007</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>215-21</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fagard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Narkiewicz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Redon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zanchetti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Böhm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2013</year>
<volume>34</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>2159-219</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molmen-Hansen]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
<name>
<surname><![CDATA[Stolen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tjonna]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Aamot]]></surname>
<given-names><![CDATA[IL]]></given-names>
</name>
<name>
<surname><![CDATA[Ekeberg]]></surname>
<given-names><![CDATA[IS]]></given-names>
</name>
<name>
<surname><![CDATA[Tyldum]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients]]></article-title>
<source><![CDATA[Eur J Prev Cardiol]]></source>
<year>2012</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>151-60</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schuler]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Goto]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Role of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectives]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2013</year>
<volume>34</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>1790-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bettencourt]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mateus]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sampaio]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Adao]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Impacto da rehabilitaçao cardíaca na qualidade de vida e sintomatología depressiva após síndrome coronaria aguda]]></article-title>
<source><![CDATA[Rev Port Cardiol]]></source>
<year>2005</year>
<volume>24</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>687-96</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lichtman]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Bigger]]></surname>
<given-names><![CDATA[JT Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Blumenthal]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Frasure-Smith]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kaufmann]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
<name>
<surname><![CDATA[Lespérance]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2008</year>
<volume>118</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>1768-75</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franklin]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Bonzheim]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Timmis]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: a 16-year follow-up]]></article-title>
<source><![CDATA[Chest]]></source>
<year>1998</year>
<volume>114</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>902-6</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Camp]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiovascular complications of outpatient cardiac rehabilitation programs]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1986</year>
<volume>256</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1160-3</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leon]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Franklin]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Balady]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Berra]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2005</year>
<volume>111</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>369-76</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Jiménez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Terzic]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zeballos]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Anchique]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Burdiat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Consenso de Rehabilitación Cardiovascular y Prevención Secundaria de las Sociedades Interamericana y Sudamericana de Cardiología]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2013</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>189-224</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burdiat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lucini]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rienzi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Incidencia de efectos adversos mayores durante un programa de rehabilitación cardíaca: tema Libre del 28º Congreso Uruguayo de Cardiología]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2012</year>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S48-9</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burdiat Rampa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Seguridad y eficacia de un programa de rehabilitación cardíaca en pacientes de alto riesgo en un medio hospitalario]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2008</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>150-6</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burdiat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lucini]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rienzi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Mejoría de la capacidad funcional de distintas poblaciones de pacientes coronarios sometidos a un programa de rehabilitación cardíaca: tema Libre del 28º Congreso Uruguayo de Cardiología]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2012</year>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S47-8</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kavanagh]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mertens]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hamm]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Beyene]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Corey]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2002</year>
<volume>106</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>666-71</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ades]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Savage]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
<name>
<surname><![CDATA[Brawner]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Lyon]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Ehrman]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Bunn]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Aerobic capacity in patients entering cardiac rehabilitation]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2006</year>
<volume>113</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>2706-12</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hammill]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Curtis]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Schulman]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Whellan]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2010</year>
<volume>121</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-70</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lawler]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Filion]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
<name>
<surname><![CDATA[Eisenberg]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>2011</year>
<volume>162</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>571-584.e2</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goel]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lennon]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tilbury]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Squires]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2011</year>
<volume>123</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>2344-52</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suaya]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Stason]]></surname>
<given-names><![CDATA[WB]]></given-names>
</name>
<name>
<surname><![CDATA[Ades]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Normand]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Shepard]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiac rehabilitation and survival in older coronary patients]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2009</year>
<volume>54</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-33</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maroto Montero]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Artigao Ramírez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Morales Durán]]></surname>
</name>
<name>
<surname><![CDATA[de Pablo Zarzosa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Abraira]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Rehabilitación cardíaca en pacientes con infarto de miocardio: resultados tras 10 años de seguimiento]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2005</year>
<volume>58</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1181-7</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oldridge]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Furlong]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Feeny]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Torrance]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Guyatt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Crowe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>1993</year>
<volume>72</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>154-61</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ades]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Weaver]]></surname>
<given-names><![CDATA[SO]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiac rehabilitation participation predicts lower rehospitalization costs]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>1992</year>
<volume>123</volume>
<numero>4 Pt 1</numero>
<issue>4 Pt 1</issue>
<page-range>916-21</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ades]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Pashkow]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Nestor]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cost-effectiveness of cardiac rehabilitation after myocardial infarction]]></article-title>
<source><![CDATA[J Cardiopulm Rehabil]]></source>
<year>1997</year>
</nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Briffa]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Eckermann]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Griffiths]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Heath]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Freedman]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial]]></article-title>
<source><![CDATA[Med J Aust]]></source>
<year>2005</year>
<volume>183</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>450-5</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="book">
<collab>Centers for Medicare and Medicaid Services</collab>
<source><![CDATA[Decision Memo for Cardiac Rehabilitation Programs (CAG-00089R)]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Baltimore ]]></publisher-loc>
<publisher-name><![CDATA[CMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="book">
<collab>American Association for Cardiovascular and Pulmonary Rehabilitation</collab>
<source><![CDATA[Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs]]></source>
<year>2004</year>
<edition>4</edition>
<publisher-loc><![CDATA[Champaign ]]></publisher-loc>
<publisher-name><![CDATA[Human Kinetics Publishers]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steg]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Atar]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Badano]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
<name>
<surname><![CDATA[Lundqvist]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Borger]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2013</year>
<volume>66</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53.e1-e46</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Azpitarte]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bardají]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabadés]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Palencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Guías de práctica clínica de la Sociedad Española de Cardiología en cirugía coronaria]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2000</year>
<volume>53</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>241-66</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espinoza Caliani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo Navas]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Doblas]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Collantes Rivera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[González Jiménez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Lao]]></surname>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Rehabilitación cardíaca postinfarto de miocardio en enfermos de bajo riesgo: Resultados de un programa de coordinación entre cardiología y atención primaria]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2004</year>
<volume>57</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53-9</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>51</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pollock]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Franklin]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Balady]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chaitman]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Fleg]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Fletcher]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2000</year>
<volume>101</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>828-33</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>52</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ehlke]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Greenwood]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Resistance Exercise for Post-Myocardial Infarction Patients: Current Guidelines and Future Considerations]]></article-title>
<source><![CDATA[Strength Cond J]]></source>
<year>2006</year>
<volume>28</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>56-62</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>53</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grima]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alegría-Ezquerra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Reporting on coronary patients for returning to work: an algorithm. ESC Councils. Council for Cardiology Practice]]></article-title>
<source><![CDATA[E-J Cardiol Pract]]></source>
<year>2012</year>
<volume>10</volume>
<numero>20</numero>
<issue>20</issue>
</nlm-citation>
</ref>
<ref id="B54">
<label>54</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Steinke]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Bakaeen]]></surname>
<given-names><![CDATA[FG]]></given-names>
</name>
<name>
<surname><![CDATA[Bozkurt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cheitlin]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Conti]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2012</year>
<volume>125</volume><volume>8</volume>
<page-range>1058-72</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>55</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tejada]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Burdiat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sandoya]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Prendez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Criado]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Evaluación de una actividad educativa al alta de pacientes coronarios: tema Libre del 27º Congreso Uruguayo de Cardiología]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2011</year>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S73</page-range></nlm-citation>
</ref>
<ref id="B56">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gambogi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Baldizzoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Albornoz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ketzoian]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saona]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Prevención secundaria en pacientes revascularizados coronarios en Uruguay: descripción de un programa, evaluación del control de los factores de riesgo y efectos en la mortalidad]]></article-title>
<source><![CDATA[Clín Investg Arterioscler]]></source>
<year>2010</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>59-69</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>57</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carlson]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Norman]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Feltz]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Franklin]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Locke]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Self-efficacy, psychosocial factors, and exercise behavior in traditional versus modified cardiac rehabilitation]]></article-title>
<source><![CDATA[J Cardiopulm Rehabil]]></source>
<year>2001</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>363-73</page-range></nlm-citation>
</ref>
<ref id="B58">
<label>58</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burdiat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Terzic]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[López Jiménez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cortes Bergoderi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Santibáñez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Situación actual de la rehabilitación cardíaca en Uruguay]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2011</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>40-7</page-range></nlm-citation>
</ref>
<ref id="B59">
<label>59</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiac rehabilitation/secondary prevention programs: a raft for the rapids: why have we missed the boat?]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2007</year>
<volume>116</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1644-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
